Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
OPEN The New England journal of medicine | 11 Dec 2020
FP Polack, SJ Thomas, N Kitchin, J Absalon, A Gurtman, S Lockhart, JL Perez, G Pérez Marc, ED Moreira, C Zerbini, R Bailey, KA Swanson, S Roychoudhury, K Koury, P Li, WV Kalina, D Cooper, RW Frenck, LL Hammitt, Ö Türeci, H Nell, A Schaefer, S Ünal, DB Tresnan, S Mather, PR Dormitzer, U Şahin, KU Jansen and WC Gruber
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently.
comments powered by Disqus
* Data courtesy of Altmetric.com